Canthaxanthine, a non-provitamin A carotenoid, has been marketed in Canada since March 1979 as a skin-tanning agent. Fifty-one individuals who ingested from 3.6 to 66 g of the drug within a 24-month period were ophthalmologically evaluated. Six of them had deposits in the ocular fundus that appeared to be related to ingestion of the substance, but no functional impairment could be detected.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[canthaxanthine retinopathy
4
retinopathy clinical
4
clinical study
4
study consumers]
4
consumers] canthaxanthine
4
canthaxanthine non-provitamin
4
non-provitamin carotenoid
4
carotenoid marketed
4
marketed canada
4
canada march
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!